Stigmasterol inhibits cancer stem cell activity in endometrial cancer by repressing IGF1R/mTOR/AKT pathway

Stigmasterol inhibits cancer stem cell activity in endometrial cancer by repressing IGF1R/mTOR/AKT pathway

Endometrial cancer (EC) is a commonly diagnosed gynecological malignancy among women worldwide. Stigmasterol is a potential natural phytosterol present in vegetable oils and seeds with anti-cancer activity. We investigate the effects of stigmasterol on the malignant properties of EC cells and the in...

Full description

Bibliographic Details
Main Authors:	Wen-Ling Wang, Shih-Ming Chen, Yueh-Chun Lee, Wen-Wei Chang
Format:	Article
Language:	English
Published:	Elsevier 2022-12-01
Series:	Journal of Functional Foods
Subjects:	Stigmasterol Phytosterol Endometrial cancer IGF1R AKT mTOR
Online Access:	http://www.sciencedirect.com/science/article/pii/S175646462200408X

Similar Items

Development of a Sensitive Bioassay for the Analysis of IGF-Related Activation of AKT/mTOR Signaling in Biological Matrices
by: Michael Walz, et al.
Published: (2021-02-01)

Targeting AKT/mTOR in Oral Cancer: Mechanisms and Advances in Clinical Trials
by: Choudhary Harsha, et al.
Published: (2020-05-01)

Inhibitors of the PI3K/Akt/mTOR Pathway in Prostate Cancer Chemoprevention and Intervention
by: Nazanin Momeni Roudsari, et al.
Published: (2021-08-01)

Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated through the Dual Modulation of Akt/mTOR Signaling Cascade
by: Jong Hyun Lee, et al.
Published: (2019-02-01)

Echinacoside exhibits antidepressant-like effects through AMPAR–Akt/ERK–mTOR pathway stimulation and BDNF expression in mice
by: Han-Wen Chuang, et al.
Published: (2022-01-01)

Akt/mTOR Targeting Activity of Resveratrol Derivatives in Non-Small Lung Cancer
by: Bhurichaya Innets, et al.
Published: (2022-11-01)

PI3K/AKT/mTOR-Targeted Therapy for Breast Cancer
by: Kunrui Zhu, et al.
Published: (2022-08-01)

MLLT11-TRIL complex promotes the progression of endometrial cancer through PI3K/AKT/mTOR signaling pathway
by: Jingnan Liao, et al.
Published: (2022-12-01)

PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies—New Therapeutic Possibilities
by: Wojciech Wiese, et al.
Published: (2023-11-01)

Carnosic Acid Induces Apoptosis and Inhibits Akt/mTOR Signaling in Human Gastric Cancer Cell Lines
by: Waseem El-Huneidi, et al.
Published: (2021-03-01)

Targeting PI3K/Akt/mTOR Pathway by Different Flavonoids: A Cancer Chemopreventive Approach
by: Torki A. Zughaibi, et al.
Published: (2021-11-01)

Orf virus induces complete autophagy to promote viral replication via inhibition of AKT/mTOR and activation of the ERK1/2/mTOR signalling pathway in OFTu cells
by: Lijun Lv, et al.
Published: (2023-03-01)

Association of Membranous WNT-1 and Nuclear mTOR with Endometrial Cancer Grade
by: Milosz Pietrus, et al.
Published: (2023-05-01)

Targeting PI3K/AKT/mTOR Signaling Pathway in Breast Cancer
by: Huayi Li, et al.
Published: (2021-07-01)

Synergistic Effects of Combination Therapy with AKT and mTOR Inhibitors on Bladder Cancer Cells
by: Hyera Kim, et al.
Published: (2020-04-01)

RRM2 Alleviates Doxorubicin-Induced Cardiotoxicity through the AKT/mTOR Signaling Pathway
by: Yuheng Jiao, et al.
Published: (2022-02-01)

Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
by: Stefano Ratti, et al.
Published: (2022-02-01)

Preclinical Efficacy and Involvement of AKT, mTOR, and ERK Kinases in the Mechanism of Sulforaphane against Endometrial Cancer
by: Rajani Rai, et al.
Published: (2020-05-01)

The Role of mTOR and eIF Signaling in Benign Endometrial Diseases
by: Tatiana S. Driva, et al.
Published: (2022-03-01)

The MuSK-BMP pathway maintains myofiber size in slow muscle through regulation of Akt-mTOR signaling
by: Diego Jaime, et al.
Published: (2024-01-01)

mTOR Signaling in Metabolism and Cancer
by: Shile Huang
Published: (2020-10-01)

The Role of mTOR Signaling as a Therapeutic Target in Cancer
by: Nadezhda V. Popova, et al.
Published: (2021-02-01)

6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis
by: Lenah S. Binmahfouz, et al.
Published: (2022-10-01)

MAPK4 predicts poor prognosis and facilitates the proliferation and migration of glioma through the AKT/mTOR pathway
by: Jing Ren, et al.
Published: (2023-05-01)

Inhibition of the AKT/mTOR pathway negatively regulates PTEN expression via miRNAs
by: Wan Linyan, et al.
Published: (2022-10-01)

GPR41 Regulates the Proliferation of BRECs via the PIK3-AKT-mTOR Pathway
by: Zitong Meng, et al.
Published: (2023-02-01)

Cyclophosphamide Inhibits PI3K/AKT/mTOR Signaling Pathway in Mice Kidneys
by: Gulsah Albayrak, et al.
Published: (2018-12-01)

PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
by: Premila D. Leiphrakpam, et al.
Published: (2024-03-01)

Mechanistic Target of Rapamycin (mTOR) in the Cancer Setting
by: James T. Murray, et al.
Published: (2018-05-01)

Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
by: Anita Thomas, et al.
Published: (2021-05-01)

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer
by: Charles N. Landen, et al.
Published: (2013-04-01)

Hesperetin Induces Autophagy and Delayed Apoptosis by Modulating the AMPK/Akt/mTOR Pathway in Human Leukemia Cells In Vitro
by: Ching-Yeh Lin, et al.
Published: (2023-02-01)

P13K/AKT/mTOR Pathway-Based Novel Biomarkers for Breast Cancer
by: Varruchi Sharma, et al.
Published: (2021-01-01)

Expression of mTOR in normal and pathological conditions
by: A Marques-Ramos, et al.
Published: (2023-07-01)

Elevated ZNF704 expression is associated with poor prognosis of uveal melanoma and promotes cancer cell growth by regulating AKT/mTOR signaling
by: Jingting Luo, et al.
Published: (2023-04-01)

Soy isoflavones induces mitophagy to inhibit the progression of osteosarcoma by blocking the AKT/mTOR signaling pathway
by: Ziang Zheng, et al.
Published: (2024-01-01)

Addressing the Reciprocal Crosstalk between the AR and the PI3K/AKT/mTOR Signaling Pathways for Prostate Cancer Treatment
by: Fabio Raith, et al.
Published: (2023-01-01)

Short-term starvation synergistically enhances cytotoxicity of Niraparib via Akt/mTOR signaling pathway in ovarian cancer therapy
by: Wang Zhi, et al.
Published: (2022-01-01)

Clinical Implications of mTOR Expression in Papillary Thyroid Cancer—A Systematic Review
by: Aleksandra Derwich, et al.
Published: (2023-03-01)

PIM Kinases and Their Relevance to the PI3K/AKT/mTOR Pathway in the Regulation of Ovarian Cancer
by: Aziz Ur Rehman Aziz, et al.
Published: (2018-02-01)